EcoDrugPlus

24-Dehydrocholesterol Reductase

Ensembl ID : ENSJJAG00000018853
Gene Symbol: DHCR24
3 Cross references
208 Possible Orthologues:

26s Protease Regulatory Subunit 7-Like

Ensembl ID : ENSJJAG00000015608
Gene Symbol: LOC101603003
1 Cross references
224 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 1 Pseudogene

Ensembl ID : ENSJJAG00000010763
Gene Symbol: LOC101615016
1 Cross references
209 Possible Orthologues:

3-Hydroxy-3-Methylglutaryl-Coa Reductase

Ensembl ID : ENSJJAG00000010723
Gene Symbol: HMGCR
3 Cross references
270 Possible Orthologues:

3-Phosphoinositide Dependent Protein Kinase 1

Ensembl ID : ENSJJAG00000013131
Gene Symbol: PDPK1
3 Cross references
240 Possible Orthologues:

4-Hydroxyphenylpyruvate Dioxygenase

Ensembl ID : ENSJJAG00000013238
Gene Symbol: HPD
3 Cross references
204 Possible Orthologues:

40s Ribosomal Protein S10

Ensembl ID : ENSJJAG00000023024
Gene Symbol: LOC101603431
3 Cross references
279 Possible Orthologues:

40s Ribosomal Protein S14

Ensembl ID : ENSJJAG00000012584
Gene Symbol: LOC101610557
2 Cross references
137 Possible Orthologues:

40s Ribosomal Protein S24 Pseudogene

Ensembl ID : ENSJJAG00000012132
Gene Symbol: LOC101607222
1 Cross references
163 Possible Orthologues:

40s Ribosomal Protein S29-Like

Ensembl ID : ENSJJAG00000011627
Gene Symbol: LOC101597159
2 Cross references
143 Possible Orthologues:

40s Ribosomal Protein S9 Pseudogene

Ensembl ID : ENSJJAG00000013812
Gene Symbol: LOC101616470
1 Cross references
218 Possible Orthologues:

5'-Nucleotidase Ecto

Ensembl ID : ENSJJAG00000022214
Gene Symbol: NT5E
3 Cross references
247 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).